DeNovo Ventures
Overview
Founded in 1996, QI Systems®, Inc. (QIS) is a Gold member of the Oracle® PartnerNetwork as an ISV and software reseller. Our executive management team offers over 75 years of combined Oracle JD Edwards EnterpriseOne and World software development and IT consulting experience. QIS's headquarters and software development office is located in Paragould, AR, with an international sales office located in Salt Lake City, UT and a Global Client Services office located in Huntington Beach, CA. \\We provide superior and patent-pending software technologies that simplify complex EnterpriseOne system-wide formula calculations with the Flexible Calculation Module (QIS FCM™) using our MESA Architecture. We also provide comprehensive customer care and billing solutions for mid market Private/Public Utilities (QIS UBSReady™) and Real Estate Property Management (QIS PMP™) JD Edwards EnterpriseOne customers.
Investment Focus
- Innovative medical device technologies
- Strong management teams
- Clear regulatory pathways
- Scalable business models
- Potential for significant market impact
Portfolio Companies
Reach DeNovo Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about DeNovo Ventures
What sectors does DeNovo Ventures invest in?
DeNovo Ventures invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Oncology, and is based in Paragould, Arkansas, United States. DeNovo Ventures is listed as a vc in the ConnectSafely investor database.
What stage does DeNovo Ventures invest at?
DeNovo Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does DeNovo Ventures invest in?
DeNovo Ventures invests across United States.
Who are the partners at DeNovo Ventures?
Team members listed for DeNovo Ventures include Mark Goedde (President and CEO) and Paul Cioni (Executive Vice President Of Operations and CTO).
What companies has DeNovo Ventures invested in?
DeNovo Ventures's portfolio includes Pulmonx, EBR Systems, Viracta Therapeutics, AxoGen, Astute Medical, EndoGastric Solutions, MyoScience and Benvenue Medical.
How do I contact DeNovo Ventures?
DeNovo Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
